Paul Gray Parker

Insider Reports History

Identity 1 identity field
Location
Oakland, CA
SEC source record 1 source field
Owner filing signature
/s/ Michael Wolf, Attorney-in-Fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paul Gray Parker

Form 4 holding Director

CLOROX CO /DE/

Security class
Deferred Stock Units
Shares / value
3,281
Estimated value
$534,448
Report date
30 Aug 2024
Price
$162.91
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CLOROX CO /DE/

Security class
Common Stock
Shares / value
978
Estimated value
$159,326
Report date
30 Sep 2024
Price
$162.91
Ownership
Direct
Form 4 holding Director

Generate Biomedicines, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
29,561
Estimated value
Report date
26 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul Gray Parker

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .